2016 Hematological Malignancies

HDR2 Study for Relapsed HL PFS by Treatment Arm (Final Analysis)

Probability 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0

P = 0.505

Standard (at 3y: 72%)

Intensified (at 3y: 67%)

12

24

36

48

60

Time, months

Josting et al, JCO 2010